Early preclinical development of PQR309, a novel balanced dual PI3K/mTOR inhibitor for treatment of various cancer types.
Saved in:
| Title: | Early preclinical development of PQR309, a novel balanced dual PI3K/mTOR inhibitor for treatment of various cancer types. |
|---|---|
| Authors: | Ettlin, R.1, Dieterle, W.1, Fabbro, D.1, Hebeisen, P.1, Beaufils, F.1, Hillmann, P.1, Stumm, M.1, Dimitrijević, S.1, Wymann, M.2, Cmiljanovic, N.1, Giese, B.1, Cmiljanovic, V.1 |
| Source: | Toxicology Letters. Oct2015 Supplement, Vol. 238, pS337-S338. 1p. |
| Database: | Environment Complete |
| ISSN: | 03784274 |
|---|---|
| DOI: | 10.1016/j.toxlet.2015.08.963 |
